Invention Grant
- Patent Title: Autologous bone graft substitute composition
-
Application No.: US17215843Application Date: 2021-03-29
-
Publication No.: US11596712B2Publication Date: 2023-03-07
- Inventor: Slobodan Vukicevic , Kuber T. Sampath , Lovorka Grgurevic , Charles Cohen , Hermann Oppermann
- Applicant: Perform Biologies, Inc.
- Applicant Address: US MA Holliston
- Assignee: Perform Biologies, Inc.
- Current Assignee: Perform Biologies, Inc.
- Current Assignee Address: US MA Holliston
- Agency: St Onge Steward Johnston and Reens LLC
- Main IPC: A61L27/36
- IPC: A61L27/36 ; A61L27/26 ; A61L27/12 ; A61L27/54 ; A61L27/02 ; A61L27/46 ; A61L27/44

Abstract:
An autologous bone graft substitute composition for inducing new bone formation, promoting bone growth and treating bone defects, a method of preparation thereof, and a method of inducing or promoting bone growth by treatment of a bone with an autologous bone graft substitute composition. The composition includes autologous blood; one or more analogs of an osteogenic bone morphogenetic protein selected from BMP-6, BMP-2, BMP-7, BMP-4, BMP-5, BMP-8, BMP-9, BMP-12, and BMP-13, and combinations thereof; and a compression resistant matrix selected from the group consisting of a bone autograft, bone allograft, hydroxyapatite, tri-calcium phosphate, and combinations thereof. The autologous blood forms a coagulum gel comprising a fibrin-meshwork reinforced with the compression resistant matrix and containing the osteogenic bone morphogenetic protein which is released over a sustained period.
Public/Granted literature
- US20210213165A1 Autologous Bone Graft Substitute Composition Public/Granted day:2021-07-15
Information query